Elevated Anticardiolipin Titer as a Stroke Factor in Young Patients in Kirkuk City Najim Raad Hassan1, Kamal Bilal Jamal2,* 1FIBMS Pathology, Clinical Immunology, MSC Interventional Cardiology 2FIBMS Internal Medicine, Kirkuk Medical College, Iraq *Corresponding Author: Bilal Jamal kamal, FIBMS Internal Medicine, Kirkuk Medical College, Iraq, Email: mithaqiraqi@gmail.com
Online published on 19 August, 2019. Abstract Introduction Stroke is a common cause of morbidity and mortality worldwide and it is the third leading cause of medical death in developed countries. Stroke can be classified into ischemic disease (80%) and hemorrhagic disease. Aim This study is conducted to assess the ACA titer as a stroke risk factor in young patients in Kirkuk city in Iraq. Method This study involved 2 study groups each one of them including 50 patients. The first group (cases) involved 50 patients diagnosed as having ischemic stroke by neurologist their ages was less than 45 years. In another group (control), 50 patients involved admitted to the same hospital with no history of prior ischemic stroke. Sera collected from both groups and freezed up to-70ºC until Anticardiolipin were measured by using enzyme linked immunosorbent assay with standard commercial lab kit (BIOLABO). Results & Conclusion Ischemic stroke according to our findings is more prevalent in those patients with Hypertension with 66% of patients in comparison to 42% of control patients with P-value of 0.0001, diabetic patients with double percentage (72%) to those in control group (36%) with P-value of 0.0001. Top Keywords Anticardiolipin, BIOLABO, Ischemic stroke, neuromedicine. Top |